Farmed Trout Disease Management and Welfare

Rainbow trout farming faces significant disease pressure, and the methods used to manage disease have direct implications for fish welfare.

Key Facts

Infectious hematopoietic necrosis and bacterial kidney disease cause significant mortality in trout farms
Antibiotic use in trout farming has declined in Norway and Canada following vaccine development
Sea lice are less of a problem in freshwater trout than in marine salmon but other parasites persist
Gill disease caused by Neoparamoeba and amoeba is a growing welfare and production concern

Welfare Considerations

Disease in farmed trout causes suffering that extends beyond mortality to chronic debilitation in surviving fish. Crowding and stress depress immune function, creating a cycle where high stocking density drives disease which in turn worsens welfare. Farms that invest in water quality monitoring, vaccination programs, and lower stocking densities report lower disease incidence and better welfare outcomes. Reducing antibiotic reliance through vaccines and biosecurity also prevents antimicrobial resistance development.

What You Can Do

Choose trout products from farms with documented disease management and antibiotic stewardship programs
Support research into vaccines for trout diseases currently treated with antibiotics
Advocate for mandatory stocking density limits and disease reporting in trout aquaculture regulations
Reduce farmed trout consumption when certified welfare alternatives are unavailable